Spain Biopharmaceutical Regulatory Affairs Market Size & Outlook
Related Markets
Spain biopharmaceutical regulatory affairs market highlights
- The Spain biopharmaceutical regulatory affairs market generated a revenue of USD 73.1 million in 2023 and is expected to reach USD 113.9 million by 2030.
- The Spain market is expected to grow at a CAGR of 6.5% from 2024 to 2030.
- In terms of segment, regulatory writing & publishing was the largest revenue generating services in 2023.
- Other Services is the most lucrative services segment registering the fastest growth during the forecast period.
Biopharmaceutical regulatory affairs market data book summary
| Market revenue in 2023 | USD 73.1 million |
| Market revenue in 2030 | USD 113.9 million |
| Growth rate | 6.5% (CAGR from 2023 to 2030) |
| Largest segment | Regulatory writing & publishing |
| Fastest growing segment | Other Services |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Regulatory Consulting, Legal Representation, Regulatory Writing & Publishing, Product Registration & Clinical Trial Applications, Other Services |
| Key market players worldwide | Genpact Ltd, Icon PLC, Promedica International, Wuxi AppTec Co Ltd, Medpace Holdings Inc, Charles River Laboratories International Inc, Labcorp Drug Development, Cencora Inc, Pharmexon, QVigilance, Voisin Consulting Life Sciences, Accell, Criterium Inc., Freyr Solutions, PharmaLex, NDA Regulatory Service GmbH, BlueReg Group, Cambridge Regulatory Services |
Other key industry trends
- In terms of revenue, Spain accounted for 1.9% of the global biopharmaceutical regulatory affairs market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, UK biopharmaceutical regulatory affairs market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 262.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Biopharmaceutical Regulatory Affairs Market Scope
Biopharmaceutical Regulatory Affairs Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Cambridge Regulatory Services | View profile | 11-50 | Saint Ives, Cambridgeshire, United Kingdom, Europe | https://cambreg.co.uk |
| Freyr Solutions | View profile | 1001-5000 | Princeton, New Jersey, United States, North America | http://www.freyrsolutions.com/ |
| BlueReg Group | View profile | 101-250 | Paris, Ile-de-France, France, Europe | https://blue-reg.com |
| QVigilance | View profile | 11-50 | Hitchin, Hertford, United Kingdom, Europe | https://www.qvigilance.com |
| NDA Regulatory Service GmbH | View profile | 101-250 | München, Bayern, Germany, Europe | http://www.ndareg.com/ |
| PharmaLex | View profile | 1001-5000 | Friedrichsdorf, Hessen, Germany, Europe | http://www.pharmalex.com/ |
| Promedica International | View profile | 11-50 | Costa Mesa, California, United States, North America | https://promedica-intl.com |
| Accell | View profile | 11-50 | Warrenton, Virginia, United States, North America | https://accellclinical.com/ |
| Labcorp Drug Development | View profile | 10001+ | Princeton, New Jersey, United States, North America | https://drugdevelopment.labcorp.com |
| Cencora Inc | View profile | 46000 | 1 West First Avenue, Conshohocken, PA, United States, 19428-1800 | https://www.cencora.com |
| Voisin Consulting Life Sciences | View profile | 251-500 | San Francisco, California, United States, North America | http://voisinconsulting.com/ |
| Pharmexon | View profile | 11-50 | Prague, Hlavni mesto Praha, Czech Republic, Europe | https://pharmexon.com |
| Medpace Holdings Inc | View profile | 5800 | 5375 Medpace Way, Cincinnati, OH, United States, 45227 | https://www.medpace.com |
| Wuxi AppTec Co Ltd | View profile | 41116 | 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai, China, People's Republic of, 200131 | https://www.wuxiapptec.com |
| Icon PLC | View profile | 41150 | South County Business Park, Leopardstown, Dublin, Ireland, D18 X5R3 | https://www.iconplc.com |
| Criterium Inc. | View profile | 101-250 | Saratoga Springs, New York, United States, North America | http://criteriuminc.com |
| Genpact Ltd | View profile | 131000 | 22 Victoria Street, Canon's Court, Hamilton, Bermuda, HM 12 | https://www.genpact.com |
| Charles River Laboratories International Inc | View profile | 21400 | 251 Ballardvale Street, Wilmington, MA, United States, 01887 | https://www.criver.com |
Spain biopharmaceutical regulatory affairs market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biopharmaceutical regulatory affairs market will help companies and investors design strategic landscapes.
Regulatory writing & publishing was the largest segment with a revenue share of 31.46% in 2023. Horizon Databook has segmented the Spain biopharmaceutical regulatory affairs market based on regulatory consulting, legal representation, regulatory writing & publishing, product registration & clinical trial applications, other services covering the revenue growth of each sub-segment from 2018 to 2030.
Spain is one of the leading markets within Europe for medical products. Small & medium-sized companies dominate 90% of the market and are responsible for more than 40% of sales.
However, large-sized companies account for around 8% to 10% of sales, generating approximately 60% of sales for the country. The demand for pharmaceutical regulatory affairs is expected to rise in the coming years as imports of medical devices from the U.S. and Germany increase.
Reasons to subscribe to Spain biopharmaceutical regulatory affairs market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Spain biopharmaceutical regulatory affairs market databook
-
Our clientele includes a mix of biopharmaceutical regulatory affairs market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Spain biopharmaceutical regulatory affairs market , including forecasts for subscribers. This country databook contains high-level insights into Spain biopharmaceutical regulatory affairs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Spain biopharmaceutical regulatory affairs market size, by services, 2018-2030 (US$M)
Spain Biopharmaceutical Regulatory Affairs Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
